Ï㽶ÊÓƵ

Douglas Fair
No Rating Available
(Learn About Our Rating System)

Douglas Fair, MD, MS, FAAP

Languages spoken: English

Clinical Locations

Primary Children's Hospital

Salt Lake City
801-662-2900

  • Dr. Fair received his medical degree from Albany Medical College, completed his Pediatric residency at UT Southwestern in Austin at Dell Children´s Hospital, and his Pediatric Hematology/ Oncology Fellowship here at the Ï㽶ÊÓƵ of Utah. He also received additional training in Clinical Research through the Masters of Science in Clinical Investigation Program at the Ï㽶ÊÓƵ of Utah. He has also received a Utah Certificate of Palliative Education (UCoPE).

    Dr. Fair joined the Ï㽶ÊÓƵ of Utah faculty in 2016 and is currently an Associate Professor of Pediatrics in the Division of Hematology/ Oncology.

    Dr. Fair serves as the Director of the Primary Children’s Hospital Solid Tumor Program. He also is the Founder and Medical Director of the Childhood, Adolescent, and Young Adult (AYA) Cancer Survivorship Program at Primary Children’s Hospital. He serves as the Director of the Huntsman Cancer Institute AYA Program and as the co-Medical Director of the Huntsman Intermountain Adolescent and Young Adult Program (HIAYA). He is the Founder and co-Medical Director of the Ï㽶ÊÓƵ of Utah, Primary Children’s Hospital, and Huntsman Cancer Institute’s Oncofertility Programs. He also co-Founded and serves as the Associate Director for the Primary Children’s Hospital Supportive Oncology for Adolescents and Pediatrics Program (SOAP).

    At the national level, Dr. Fair serves on numerous committees and steering committees. Some of these include serving on the steering committees for the Soft Tissue Sarcoma Group and Rare Tumor Group within the Children’s Oncology Group (COG). He is also a member of the AYA Responsible Investigator (RI) Group within COG. He serves on many National Comprehensive Cancer Network (NCCN) AYA Guideline Committees. He is also a leader in the Oncofertility Consortium and a member of the Pediatric Initiative Network (PIN). He also serves on advisory boards for numerous non-profit and philanthropic organizations benefiting pediatric and AYA cancer causes. Dr. Fair has also been active in advocating for gaps in insurance coverage for cancer patients, playing a lead role in changing policy at the insurance provider and legislative level.

    Dr. Fair´s research interests include improving survival outcomes for children and AYAs diagnosed with solid tumors, specifically clinical trial development for sarcomas and rare tumors. He is also involved in research investigating improved outcomes and care for survivors of pediatric and AYA cancer. Another area of research is the gonadal and fertility function of cancer survivors, and the understanding of the gonadal toxic and gonadal protective agents in cancer therapy

    Specialties

    Board Certification

    American Board of Pediatrics (Pediatrics)
    American Board of Pediatrics (Sub: Pediatric Hematology-Oncology)

  • Dr. Fair received his medical degree from Albany Medical College, completed his Pediatric residency at UT Southwestern in Austin at Dell Children´s Hospital, and his Pediatric Hematology/ Oncology Fellowship here at the Ï㽶ÊÓƵ of Utah. He also received additional training in Clinical Research through the Masters of Science in Clinical Investigation Program at the Ï㽶ÊÓƵ of Utah. He has also received a Utah Certificate of Palliative Education (UCoPE).

    Dr. Fair joined the Ï㽶ÊÓƵ of Utah faculty in 2016 and is currently an Associate Professor of Pediatrics in the Division of Hematology/ Oncology.

    Dr. Fair serves as the Director of the Primary Children’s Hospital Solid Tumor Program. He also is the Founder and Medical Director of the Childhood, Adolescent, and Young Adult (AYA) Cancer Survivorship Program at Primary Children’s Hospital. He serves as the Director of the Huntsman Cancer Institute AYA Program and as the co-Medical Director of the Huntsman Intermountain Adolescent and Young Adult Program (HIAYA). He is the Founder and co-Medical Director of the Ï㽶ÊÓƵ of Utah, Primary Children’s Hospital, and Huntsman Cancer Institute’s Oncofertility Programs. He also co-Founded and serves as the Associate Director for the Primary Children’s Hospital Supportive Oncology for Adolescents and Pediatrics Program (SOAP).

    At the national level, Dr. Fair serves on numerous committees and steering committees. Some of these include serving on the steering committees for the Soft Tissue Sarcoma Group and Rare Tumor Group within the Children’s Oncology Group (COG). He is also a member of the AYA Responsible Investigator (RI) Group within COG. He serves on many National Comprehensive Cancer Network (NCCN) AYA Guideline Committees. He is also a leader in the Oncofertility Consortium and a member of the Pediatric Initiative Network (PIN). He also serves on advisory boards for numerous non-profit and philanthropic organizations benefiting pediatric and AYA cancer causes. Dr. Fair has also been active in advocating for gaps in insurance coverage for cancer patients, playing a lead role in changing policy at the insurance provider and legislative level.

    Dr. Fair´s research interests include improving survival outcomes for children and AYAs diagnosed with solid tumors, specifically clinical trial development for sarcomas and rare tumors. He is also involved in research investigating improved outcomes and care for survivors of pediatric and AYA cancer. Another area of research is the gonadal and fertility function of cancer survivors, and the understanding of the gonadal toxic and gonadal protective agents in cancer therapy

    Board Certification and Academic Information

    Academic Departments Pediatrics -Primary
    Academic Divisions Hematology/Oncology
    Board Certification
    American Board of Pediatrics (Pediatrics)
    American Board of Pediatrics (Sub: Pediatric Hematology-Oncology)

    Education history

    Graduate Training Clinical Research - Ï㽶ÊÓƵ of Utah M.S.C.I
    Pediatric Hematology/Oncology - Ï㽶ÊÓƵ of Utah Fellow
    Internship Pediatrics - Ï㽶ÊÓƵ of Texas Southwestern – Austin Intern
    Pediatrics - Ï㽶ÊÓƵ of Texas Southwestern – Austin Resident
    Professional Medical Medicine - Albany Medical College M.D.
    Biology/ Philosophy - Siena College B.A.

    Selected Publications

    Journal Article

    1. Schoettler PJ, Smith CC, Nishitani M, Harris AK, Nelson AT, Watson DA, Kamihara J, Mullen EA, Hill DA, Messinger YH, Fair DB, Kumar KA, Dehner LP, Ash S, Chen KS, Schultz KAP (2024). Anaplastic sarcoma of the kidney (DICER1-sarcoma of the kidney): A report from the International Pleuropulmonary Blastoma/DICER1 Registry. Pediatr Blood Cancer, 71(8), e31090. ()
    2. Bagatell R, Park JR, Acharya S, Aldrink J, Allison J, Alva E, Arndt C, Benedetti D, Brown E, Cho S, Church A, Davidoff A, Desai AV, DuBois S, Fair D, Farinhas J, Harrison D, Huang F, Iskander P, Kreissman S, Macy M, Na B, Pashankar F, Pendyala P, Pinto N, Polites S, Rabah R, Shimada H, Slatnick L, Sokol E, Twist C, Vo K, Watt T, Wolden S, Zage P, Schonfeld R, Hang L (2024). Neuroblastoma, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw, 22(6), 413-433. ()
    3. Kirchhoff AC, van Thiel Berghuijs KM, Waters AR, Kaddas HK, Warner EL, Vaca Lopez PL, Perez GK, Ray N, Chevrier A, Allen K, Fair DB, Tsukamoto T, Lewis MA, Haaland B, Park ER (2023). Health Insurance Literacy Improvements Among Recently Diagnosed Adolescents and Young Adults With Cancer: Results From a Pilot Randomized Controlled Trial. JCO Oncol Pract, OP2300171. ()
    4. Ou JY, Waters AR, Kaddas HK, Warner EL, Lopez PLV, Mann K, Anderson JS, Ray N, Tsukamoto T, Gill D, Linder L, Fair D, Kirchhoff AC (2022). Financial burdens during the COVID-19 pandemic are related to disrupted healthcare utilization among survivors of adolescent and young adult cancers. J Cancer Surviv, 17(6), 1571-1582. ()
    5. van Thiel Berghuijs KM, Kaddas HK, Warner EL, Fair DB, Fluchel M, Knackstedt ED, Verma A, Kepka D, Green AL, Smitherman AB, Draper L, Johnson RH, Kirchhoff AC (2023). Vaccination practices of pediatric oncologists from eight states. BMC Health Serv Res, 23(1), 1215. ()
    6. Vaca Lopez PL, Warner EL, Waters AR, van Thiel Berghuijs KM, Anderson JS, Ray N, Tsukamoto T, Kaddas HK, Fair D, Lewis M, Park ER, Perez GK, Kirchhoff AC (2023). Adaptation and Development of a Health Insurance Education Program for Adolescent and Young Adult Cancer Patients. J Adolesc Young Adult Oncol, 12(5), 692-700. ()
    7. Waters AR, Kaddas HK, van Thiel Berghuijs KM, Vaca Lopez PL, Warner EL, Ou JY, Ramsay JM, Palmer A, Ray N, Tsukamoto T, Fair DB, Lewis MA, Linder L, Gill D, Kirchhoff AC (2023). COVID-19-Related Employment Disruptions and Increased Financial Burden Among Survivors of Adolescent and Young Adult Cancer. J Adolesc Young Adult Oncol, 12(5), 744-751. ()
    8. Merjaneh N, Kim H, Escoto H, Metts J, Ray A, Bukowinski A, LeBlanc Z, Fair D, Watanbe M, Alva E, Todd K, Daley J, Hartt D, Cramer SL, Szabo S, Pressey JG (2023). Strategies for the Treatment of Infantile Soft Tissue Sarcomas With BCOR Alterations. J Pediatr Hematol Oncol, 45(6), 315-321. ()
    9. Bhatia S, Pappo AS, Acquazzino M, Allen-Rhoades WA, Barnett M, Borinstein SC, Casey R, Choo S, Chugh R, Dinner S, Ermoian R, Fair D, Federman N, Folbrecht J, Gandhi S, Germann J, Goldsby R, Hayashi R, Huang AY, Huang MS, Jacobs LA, Lee-Miller C, Link MP, Livingston JA, Lustberg M, Malogolowkin M, Oeffinger KC, Pratilas CA, Reed D, Skiles J, von Mehren M, Yeager N, Montgomery S, Hang L (2023). Adolescent and Young Adult (AYA) Oncology, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw, 21(8), 851-880. ()
    10. Lautz TB, Xue W, Luo LY, Fair D, Qumseya A, Gao Z, Dasgupta R, Rodeberg D, Venkatramani R (2023). Management and outcomes of chest wall rhabdomyosarcoma: A report from the Children's Oncology Group Soft Tissue Sarcoma Committee. Pediatr Blood Cancer, 70(7), e30357. ()
    11. Fair D, Maese L, Chi YY, Li M, Hawkins DS, Venkatramani R, Rudzinski E, Parham D, Teot L, Malkin D, Plon SE, Li H, Sabo A, Lupo PJ, Schiffman JD (2023). TP53 germline pathogenic variant frequency in anaplastic rhabdomyosarcoma: A Children's Oncology Group report. Pediatr Blood Cancer, e30413. ()
    12. Ou JY, Bennion N, Parker K, Fair D, Hanson HA, Kepka D, Warner EL, Ramsay JM, Kaddas HK, Kirchhoff AC (2022). Risk Factors and Trends for HPV-Associated Subsequent Malignant Neoplasms among Adolescent and Young Adult Cancer Survivors. Cancer Epidemiol Biomarkers Prev, 32(5), 625-633. ()
    13. Kaddas HK, Ramsay JM, Ou JY, Fair D, Kepka D, Kirchhoff AC (2022). HPV Vaccination Initiation and Completion Among Pediatric, Adolescent, and Young Adult Cancer Survivors and a Comparison Population Sample Receiving Primary Care. J Pediatr Hematol Oncol, 45(2), e236-e243. ()
    14. Waters AR, van Thiel Berghuijs KM, Kaddas HK, Vaca Lopez PL, Chevrier A, Ray N, Tsukamoto T, Allen K, Fair DB, Lewis MA, Perez GK, Park ER, Kirchhoff AC, Warner EL (2023). Sources of informal financial support among adolescent and young adult cancer survivors: a mixed methods analysis from the HIAYA CHAT study. Support Care Cancer, 31(3), 159. ()
    15. Mann K, Waters AR, Park ER, Perez GK, Vaca Lopez PL, Kaddas HK, Warner EL, Ray N, Tsukamoto T, Allen K, Haaland B, Fair DB, Lewis MA, Kirchhoff AC (2022). HIAYA CHAT study protocol: a randomized controlled trial of a health insurance education intervention for newly diagnosed adolescent and young adult cancer patients. Trials, 23(1), 682. ()
    16. Cooper LJ, Emery BR, Aston K, Fair D, Rosen MP, Johnstone E, Letourneau JM (2022). Fertility preservation practices for female oncofertility differ significantly across the USA: results of a survey of SREI members. J Assist Reprod Genet, 39(8), 1749-1757. ()
    17. Waters AR, Mann K, Warner EL, Vaca Lopez PL, Kaddas HK, Ray N, Tsukamoto T, Fair DB, Lewis MA, Perez GK, Park ER, Kirchhoff AC (2022). "I thought there would be more I understood": health insurance literacy among adolescent and young adult cancer survivors. Support Care Cancer, 30(5), 4457-4464. ()
    18. Avutu V, Monga V, Mittal N, Saha A, Andolina JR, Bell DE, Fair DB, Flerlage JE, Frediani JN, Heath JL, Kahn JM, Reichek JL, Super L, Terao MA, Freyer DR, Roth ME (2021). Use of Communication Technology to Improve Clinical Trial Participation in Adolescents and Young Adults With Cancer: Consensus Statement From the Children's Oncology Group Adolescent and Young Adult Responsible Investigator Network. JCO Oncol Pract, OP2100554. ()
    19. Fair D, Park ER, Nipp RD, Rabin J, Hyland K, Kuhlthau K, Perez GK, Nathan PC, Armstrong GT, Oeffinger KC, Robison LL, Leisenring W, Kirchhoff AC (2021). Material, behavioral, and psychological financial hardship among survivors of childhood cancer in the Childhood Cancer Survivor Study. Cancer, 127(17), 3214-3222. ()
    20. Waters AR, Kepka D, Ramsay JM, Mann K, Vaca Lopez PL, Anderson JS, Ou JY, Kaddas HK, Palmer A, Ray N, Tsukamoto T, Fair DB, Lewis MA, Kirchhoff AC, Warner EL (2021). COVID-19 Vaccine Hesitancy Among Adolescent and Young Adult Cancer Survivors. JNCI Cancer Spectr, 5(3), pkab049. ()
    21. Woodruff TK, Ataman-Millhouse L, Acharya KS, Almeida-Santos T, Anazodo A, Anderson RA, Appiah L, Bader J, Becktell K, Brannigan RE, Breech L, Bourlon MT, Bumbuliene, Burns K, Campo-Engelstein L, Campos JR, Centola GM, Chehin MB, Chen D, De Vos M, Duncan FE, El-Damen A, Fair D, Famuyiwa Y, Fechner PY, Fontoura P, Frias O, Gerkowicz SA, Ginsberg J, Gracia CR, Goldman K, Gomez-Lobo V, Hazelrigg B, Hsieh MH, Hoyos LR, Hoyos-Martinez A, Jach R, Jassem J, Javed M, Jayasinghe Y, Jeelani R, Jeruss JS, Kaul-Mahajan N, Keim-Malpass J, Ketterl TG, Khrouf M, Kimelman D, Kusuhara A, Kutteh WH, Laronda MM, Lee JR, Lehmann V, Letourneau JM, McGinnis LK, McMahon E, Meacham LR, Mijangos MFV, Moravek M, Nahata L, Ogweno GM, Orwig KE, Pavone ME, Peccatori FA, Pesce RI, Pulaski H, Quinn G, Quintana R, Quintana T, de Carvalho BR, Ramsey-Goldman R, Reinecke J, Reis FM, Rios J, Rhoton-Vlasak AS, Rodriguez-Wallberg KA, Roeca C, Rotz SJ, Rowell E, Salama M, Saraf AJ, Scarella A, Schafer-Kalkhoff T, Schmidt D, Senapati S, Shah D, Shikanov A, Shnorhavorian M, Skiles JL, Smith JF, Smith K, Sobral F, Stimpert K, Su HI, Sugimoto K, Suzuki N, Thakur M, Victorson D, Viale L, Vitek W, Wallace WH, Wartella EA, Westphal LM, Whiteside S, Wilcox LH, Wyns C, Xiao S, Xu J, Zelinski M (2021). A View from the past into our collective future: the oncofertility consortium vision statement. J Assist Reprod Genet, 38(1), 3-15. ()
    22. Carter-Febres M, Schneller N, Fair D, Solomon D, Perry A, Roy A, Linscott L, Alashari M, Kestle JR, Bruggers CS (2020). Adjuvant Maintenance Larotrectinib Therapy in 2 Children With NTRK Fusion-positive High-grade Cancers. J Pediatr Hematol Oncol, 43(7), e987-e990. ()
    23. Warner EL, Vaca Lopez PL, Kepka D, Mann K, Kaddas HK, Fair D, Fluchel M, Knackstedt ED, Pannier ST, Martel L, Kirchhoff AC (2020). Influence of provider recommendations to restart vaccines after childhood cancer on caregiver intention to vaccinate. J Cancer Surviv, 14(5), 757-767. ()
    24. Kaddas HK, Pannier ST, Mann K, Waters AR, Salmon S, Tsukamoto T, Warner EL, Fowler B, Lewis MA, Fair DB, Kirchhoff AC (2019). Age-Related Differences in Financial Toxicity and Unmet Resource Needs Among Adolescent and Young Adult Cancer Patients. J Adolesc Young Adult Oncol, 9(1), 105-110. ()
    25. Fair D, Potter SL, Venkatramani R (2019). Challenges and solutions to the study of rare childhood tumors. Curr Opin Pediatr, 32(1), 7-12. ()
    26. Letourneau J, Fair D (2019). Oncofertility in urologic oncology: Fertility preservation for women undergoing cancer treatment. Urol Oncol, 38(1), 14-22. ()
    27. Garg D, Johnstone EB, Fair DB, Carrell DT, Berga S, Letourneau JM (2019). Oncofertility conundrum: discrepancy between anti-MÏ‹llerian hormone and mature oocyte yield in a peripubertal girl with Hodgkin lymphoma. J Assist Reprod Genet, 36(8), 1753-1756. ()
    28. Kirchhoff AC, Mann K, Warner EL, Kaddas HK, Fair D, Fluchel M, Knackstedt ED, Kepka D (2019). HPV vaccination knowledge, intentions, and practices among caregivers of childhood cancer survivors. Hum Vaccin Immunother, 15(7-8), 1767-1775. ()
    29. Warner EL, Fowler B, Pannier ST, Salmon SK, Fair D, Spraker-Perlman H, Yancey J, Randall RL, Kirchhoff AC (2018). Patient Navigation Preferences for Adolescent and Young Adult Cancer Services by Distance to Treatment Location. J Adolesc Young Adult Oncol, 7(4), 438-444. ()
    30. Kaul S, Fair D, Wright J, Kirchhoff AC (2016). Dental Care for Survivors of Adolescent and Young Adult Cancer: Special Considerations. J Adolesc Young Adult Oncol, 5(2), 152-8. ()

    Case Report

    1. Carter-Febres M, Schneller N, Fair D, Solomon D, Perry A, Roy A, Linscott L, Alashari M, Kestle JR, Bruggers CS (2020). Adjuvant Maintenance Larotrectinib Therapy in 2 Children With NTRK Fusion-positive High-grade Cancers. J Pediatr Hematol Oncol, 43(7), e987-e990. ()

  • News & Podcasts

    Podcasts